Subsequent Events (Details Textual) - Invagen Pharmaceuticals Inc [Member] - USD ($) $ / shares in Units, $ in Millions |
Feb. 08, 2019 |
Nov. 12, 2018 |
|---|---|---|
| Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $ 215.0 | |
| Subsequent Event [Member] | ||
| Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $ 31.5 | |
| Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 5,833,333 | |
| Business Acquisition, Share Price | $ 6.00 | |
| Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 33.30% |
| X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|